AstraZeneca Eyes Gilead in Big Pharma’s Move Beyond Covid

(Bloomberg) -- Two drugmakers behind the industry’s most prominent responses to the Covid-19 pandemic are looking into the possibility of a combined future as economies emerge from lockdowns.